[Vascular agents can prevent type 2 diabetes].
Nilsson
Peter
P
Avdelningen för medicin, Universitetssjukhuset MAS, Malmö. Peter.Nilsson@medforsk.mas.lu.se
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D006801:Humans; D017410:Practice Guidelines as Topic
D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents